Jim Simons Applied Genetic Technologies Corp Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.29 - $0.89 $241,212 - $740,273
831,768 Added 272.05%
1,137,508 $309,000
Q2 2022

Aug 12, 2022
BUY
$0.62 - $1.1 $115,878 - $205,590
186,900 Added 157.27%
305,740 $235,000
Q1 2022

May 13, 2022
BUY
$1.07 - $2.71 $32,100 - $81,300
30,000 Added 33.77%
118,840 $127,000
Q4 2021

Feb 11, 2022
BUY
$1.87 - $2.91 $72,930 - $113,490
39,000 Added 78.25%
88,840 $169,000
Q3 2021

Nov 12, 2021
SELL
$3.01 - $4.12 $320,264 - $438,368
-106,400 Reduced 68.1%
49,840 $150,000
Q2 2021

Aug 13, 2021
SELL
$3.62 - $5.23 $1.59 Million - $2.3 Million
-439,900 Reduced 73.79%
156,240 $611,000
Q1 2021

May 13, 2021
SELL
$3.94 - $8.19 $1.66 Million - $3.45 Million
-420,700 Reduced 41.37%
596,140 $3.02 Million
Q4 2020

Feb 10, 2021
SELL
$3.99 - $5.7 $210,672 - $300,960
-52,800 Reduced 4.94%
1,016,840 $4.16 Million
Q3 2020

Nov 13, 2020
SELL
$4.38 - $6.43 $668,388 - $981,218
-152,600 Reduced 12.49%
1,069,640 $5.2 Million
Q2 2020

Aug 13, 2020
SELL
$3.0 - $6.9 $529,407 - $1.22 Million
-176,469 Reduced 12.62%
1,222,240 $6.77 Million
Q1 2020

May 14, 2020
BUY
$2.36 - $9.86 $435,110 - $1.82 Million
184,369 Added 15.18%
1,398,709 $4.59 Million
Q4 2019

Feb 13, 2020
BUY
$2.69 - $4.92 $439,223 - $803,337
163,280 Added 15.53%
1,214,340 $5.49 Million
Q3 2019

Nov 13, 2019
BUY
$2.59 - $4.16 $241,543 - $387,961
93,260 Added 9.74%
1,051,060 $4.37 Million
Q2 2019

Aug 12, 2019
BUY
$3.6 - $4.78 $256,320 - $340,336
71,200 Added 8.03%
957,800 $3.63 Million
Q1 2019

May 14, 2019
BUY
$2.62 - $4.44 $100,870 - $170,940
38,500 Added 4.54%
886,600 $3.72 Million
Q4 2018

Feb 13, 2019
BUY
$2.28 - $7.15 $1.93 Million - $6.06 Million
848,100 New
848,100 $2.11 Million

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email